Compare TRDA & TASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRDA | TASK |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 500.4M | 585.9M |
| IPO Year | 2021 | 2021 |
| Metric | TRDA | TASK |
|---|---|---|
| Price | $12.65 | $6.54 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 5 |
| Target Price | ★ $21.00 | $14.70 |
| AVG Volume (30 Days) | 144.6K | ★ 571.1K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 120.00 |
| EPS | N/A | ★ 1.10 |
| Revenue | ★ $25,421,000.00 | N/A |
| Revenue This Year | $39.97 | $5.95 |
| Revenue Next Year | $50.80 | $6.46 |
| P/E Ratio | ★ N/A | $5.90 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.93 | $6.20 |
| 52 Week High | $14.49 | $18.39 |
| Indicator | TRDA | TASK |
|---|---|---|
| Relative Strength Index (RSI) | 46.56 | 34.71 |
| Support Level | $10.84 | $6.30 |
| Resistance Level | $12.93 | $7.54 |
| Average True Range (ATR) | 0.58 | 0.33 |
| MACD | -0.19 | 0.09 |
| Stochastic Oscillator | 23.92 | 22.66 |
Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.
TaskUs Inc provides outsourced digital services. Its service offerings include Digital Customer Experience consists of omnichannel customer care services, delivered through digital (non-voice) channels, also including learning experience and sales and customer acquisition services; Trust & Safety consists of monitoring, reviewing and managing user and advertiser-generated content on online platforms to ensure it complies with community guidelines, legal regulations and platform specific policies; and AI Services consists of large language model support and high-quality data labeling services, annotation, context relevance and transcription services performed for the purpose of training and tuning machine learning algorithms, enabling them to develop cutting-edge AI systems.